MUMBAI, Nov 7 (Reuters) - India's Dr Reddy's Laboratories (REDY.BO) has filed for marketing a generic version of Pfizer's (PFE.N) cholesterol-lowering drug Lipitor in the U.S., the company said on Saturday.